1. Humoral immune response in multiple sclerosis patients following PfizerBNT162b2 COVID19 vaccination: Up to 6 months cross-sectional study;Achiron;J. Neuroimmunol.,2021
2. The state of complement in COVID-19;Afzali;Nat. Rev. Immunol.,2021
3. Complement Evasion Strategies of Viruses: An Overview;Agrawal;Front. Microbiol.,2017
4. COVID-19 and the Heart;Akhmerov;Circ. Res,2020
5. Aleem, A., Akbar Samad, A.B., Slenker, A.K. , 2022. Emerging Variants of SARS-CoV-2 And Novel Therapeutics Against Coronavirus (COVID-19). In StatPearls (Treasure Island (FL)).